These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 24885361)
1. The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. Enns JE; Yeganeh A; Zarychanski R; Abou-Setta AM; Friesen C; Zahradka P; Taylor CG BMC Cardiovasc Disord; 2014 May; 14():70. PubMed ID: 24885361 [TBL] [Abstract][Full Text] [Related]
2. The effect of oral omega-3 polyunsaturated fatty acid supplementation on muscle maintenance and quality of life in patients with cancer: A systematic review and meta-analysis. Lam CN; Watt AE; Isenring EA; de van der Schueren MAE; van der Meij BS Clin Nutr; 2021 Jun; 40(6):3815-3826. PubMed ID: 34130028 [TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials. Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Yan J; Liu M; Yang D; Zhang Y; An F Cardiovasc Drugs Ther; 2024 Aug; 38(4):799-817. PubMed ID: 36103100 [TBL] [Abstract][Full Text] [Related]
5. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891 [TBL] [Abstract][Full Text] [Related]
6. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Viecelli AK; Irish AB; Polkinghorne KR; Hawley CM; Johnson DW; Mori TA; Pascoe EM; Strippoli GFM; Lok CE; Palmer SC Am J Kidney Dis; 2018 Jul; 72(1):50-61. PubMed ID: 29395485 [TBL] [Abstract][Full Text] [Related]
7. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):808-18. PubMed ID: 23110790 [TBL] [Abstract][Full Text] [Related]
8. Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Lower Extremity Arterial Disease. Su MI; Cheng YC; Huang YC; Liu CW J Am Nutr Assoc; 2022; 41(4):383-391. PubMed ID: 33750272 [TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated Fatty Acids and Chronic Pain: A Systematic Review and Meta-analysis. Prego-Dominguez J; Hadrya F; Takkouche B Pain Physician; 2016; 19(8):521-535. PubMed ID: 27906932 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acid supplementation for improving peripheral nerve health: protocol for a systematic review. Zhang AC; MacIsaac RJ; Roberts L; Kamel J; Craig JP; Busija L; Downie LE BMJ Open; 2018 Mar; 8(3):e020804. PubMed ID: 29581208 [TBL] [Abstract][Full Text] [Related]
11. Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease. Downie LE; Ng SM; Lindsley KB; Akpek EK Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011016. PubMed ID: 31847055 [TBL] [Abstract][Full Text] [Related]
12. Omega-3 Polyunsaturated Fatty Acids Supplements and Cardiovascular Disease Outcome: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Qi X; Zhu H; Ya R; Huang H Rev Cardiovasc Med; 2023 Jan; 24(1):24. PubMed ID: 39076869 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Marik PE; Varon J Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891 [TBL] [Abstract][Full Text] [Related]